|
|
cell fate determination
|
GO:0001709 |
3 |
0.927
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.852
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.655
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.655
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.630
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
0.623
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.622
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.621
|
|
|
|
menstrual cycle phase
|
GO:0022601 |
2 |
0.618
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.613
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.595
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.574
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.548
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.527
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.521
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.516
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
2 |
0.509
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
3 |
0.500
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.491
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.486
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.482
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.463
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.462
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.460
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.445
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.443
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.441
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.433
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.433
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.427
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.425
|
|
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.417
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
45 |
0.412
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.402
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.402
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.393
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.391
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.389
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.384
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.381
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.368
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.366
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.352
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.333
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.322
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.315
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.309
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.301
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.299
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.299
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.296
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.294
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.282
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.279
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.272
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.263
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.257
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.257
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.254
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.251
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.249
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.247
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.247
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.245
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.243
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.242
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.240
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.235
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.230
|
|
|
|
head development
|
GO:0060322 |
108 |
0.226
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.219
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.217
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.216
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.211
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
76 |
0.207
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.207
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.206
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.201
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.200
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.200
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.196
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.193
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.193
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
4 |
0.192
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.192
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
47 |
0.191
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.190
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.189
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.185
|
|
|
|
odontogenesis
|
GO:0042476 |
25 |
0.183
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.183
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.183
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.177
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.177
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.177
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.175
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.171
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.170
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.170
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.168
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.168
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.166
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.166
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.165
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.165
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.162
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.161
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
39 |
0.159
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.158
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.155
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.155
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.154
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.154
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.153
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.151
|
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.150
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.150
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.148
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
4 |
0.148
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.148
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.147
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.145
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.143
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.142
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.142
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.140
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.138
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.137
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.137
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.136
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.136
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.133
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.132
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.132
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.131
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.130
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.129
|
|
|
|
right ventricular cardiac muscle tissue morphogenesis
|
GO:0003221 |
2 |
0.129
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.129
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.128
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.127
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.126
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.125
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.125
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.125
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.124
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.122
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.121
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
26 |
0.120
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.119
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.119
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.118
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.118
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.118
|
|
|
|
embryonic digestive tract morphogenesis
|
GO:0048557 |
2 |
0.118
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.117
|
|
|
|
regulation of excretion
|
GO:0044062 |
1 |
0.116
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.116
|
|
|
|
bone mineralization
|
GO:0030282 |
34 |
0.116
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.115
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.114
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.114
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.114
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.113
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
48 |
0.113
|
|
|
|
modulation by host of viral transcription
|
GO:0043921 |
20 |
0.112
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.111
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.110
|
|
|
|
regulation of myelination
|
GO:0031641 |
1 |
0.109
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.108
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.108
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.107
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.107
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.107
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.107
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.106
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.104
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.102
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.101
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.101
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.100
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.100
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.100
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.099
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.099
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.097
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.097
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.096
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.096
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.095
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.095
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.095
|
|
|
|
negative regulation of fibroblast growth factor receptor signaling pathway
|
GO:0040037 |
2 |
0.094
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.093
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.093
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.092
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.091
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.090
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
29 |
0.089
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.088
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.088
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.088
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.088
|
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.087
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.087
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.087
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.087
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.087
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.087
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.086
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
3 |
0.086
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.086
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.085
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.084
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.083
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.083
|
|
|
|
heparan sulfate proteoglycan biosynthetic process
|
GO:0015012 |
8 |
0.083
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
38 |
0.083
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.083
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.083
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.082
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.082
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.082
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.082
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.082
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.081
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.080
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.079
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.078
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
6 |
0.078
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.077
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.077
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.077
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.077
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
23 |
0.076
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.075
|
|
|
|
growth
|
GO:0040007 |
202 |
0.075
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.074
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.074
|
|
|
|
system process
|
GO:0003008 |
349 |
0.074
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.074
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.074
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.072
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.072
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.072
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.072
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.072
|
|
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.072
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.071
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.071
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.070
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.070
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
22 |
0.070
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.069
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.069
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.069
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.069
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.068
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.067
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
22 |
0.067
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.067
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.066
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.065
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.065
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.065
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.064
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.063
|
|
|
|
regulation of glycoprotein metabolic process
|
GO:1903018 |
19 |
0.063
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.063
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.062
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.062
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.062
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.061
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.061
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.061
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.060
|
|
|
|
canonical wnt signaling pathway involved in mesenchymal stem cell differentiation
|
GO:0044338 |
2 |
0.060
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.060
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.060
|
|
|
|
regulation of cell cell adhesion
|
GO:0022407 |
57 |
0.060
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.060
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.060
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.059
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.059
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
41 |
0.059
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.058
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.058
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.058
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.058
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.057
|
|
|
|
mesodermal cell fate specification
|
GO:0007501 |
2 |
0.057
|
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.057
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.056
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.056
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.056
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.056
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.056
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.056
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.056
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
4 |
0.056
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.056
|
Mouse |
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.056
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.056
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.055
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.055
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.055
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.055
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.055
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.055
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.055
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.055
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.054
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.054
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.054
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.054
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.053
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.053
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.053
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.053
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.053
|
|
|
|
catenin import into nucleus
|
GO:0035411 |
18 |
0.053
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.053
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.053
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.053
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.052
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.052
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.051
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
48 |
0.051
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.051
|
|
|
|
positive regulation of epithelial cell proliferation involved in wound healing
|
GO:0060054 |
3 |
0.051
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.051
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
2 |
0.051
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
16 |
0.051
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
3 |
0.051
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
41 |
0.050
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.050
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.050
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.050
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.050
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.050
|
|
|
|
regulation of smooth muscle cell proliferation
|
GO:0048660 |
28 |
0.049
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.049
|
|
|
|
positive regulation of aldosterone biosynthetic process
|
GO:0032349 |
2 |
0.049
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.049
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.049
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.049
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.048
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.048
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.048
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.048
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.048
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.047
|
|
|
|
neuronal action potential
|
GO:0019228 |
9 |
0.047
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.047
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.047
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.047
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.047
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.047
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
24 |
0.047
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.047
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
45 |
0.046
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.046
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.046
|
|
|
|
forebrain dorsal ventral pattern formation
|
GO:0021798 |
1 |
0.046
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.046
|
|
|
|
dermatome development
|
GO:0061054 |
3 |
0.046
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.046
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.046
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
61 |
0.046
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.045
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.045
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
17 |
0.045
|
|
|
|
regulation of male gonad development
|
GO:2000018 |
4 |
0.045
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.044
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.044
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.044
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.044
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.044
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.044
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.043
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.043
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.043
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.043
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
27 |
0.043
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.042
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.042
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.042
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.042
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.042
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.042
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.041
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.041
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
22 |
0.041
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.041
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.041
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.040
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.040
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.040
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.040
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.040
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.040
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.040
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.040
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.040
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.040
|
|
|
|
outflow tract septum morphogenesis
|
GO:0003148 |
4 |
0.040
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.039
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.039
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.039
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.039
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.039
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.039
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.039
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.039
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.039
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.039
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.039
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.038
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.038
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.038
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.038
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.038
|
|
|
|
regulation of hormone metabolic process
|
GO:0032350 |
14 |
0.038
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.038
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.038
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.038
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.038
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.038
|
|
|
|
canonical wnt signaling pathway involved in negative regulation of apoptotic process
|
GO:0044336 |
2 |
0.038
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.038
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.038
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
76 |
0.038
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.038
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.037
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.037
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.037
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.037
|
|
|
|
negative regulation of cell fate commitment
|
GO:0010454 |
3 |
0.037
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.037
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.037
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.036
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.036
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.036
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.036
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.036
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.036
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.036
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.036
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
85 |
0.035
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.035
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
24 |
0.035
|
|
|
|
specification of axis polarity
|
GO:0065001 |
1 |
0.035
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.035
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.035
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
39 |
0.035
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.035
|
|
|
|
regulation of organ formation
|
GO:0003156 |
4 |
0.035
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.035
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.034
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.034
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.034
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.034
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.034
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.034
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.034
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.034
|
|
|
|
regulation of insulin secretion
|
GO:0050796 |
33 |
0.034
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.034
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.034
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.033
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.033
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.033
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.033
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.033
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.033
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.033
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.033
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.033
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.033
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.033
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.033
|
|
|
|
negative regulation of interleukin 4 production
|
GO:0032713 |
3 |
0.033
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.033
|
|
